Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Defining AF Cardiomyopathy
Author(s): Nikhil Ahluwalia , Shohreh Honarbakhsh , Ross Hunter , et al Added: 1 month ago

Electrophysiology & Arrhythmia

Heart Failure
Heart Disease in Pregnancy: Maternal and Neonatal Risk
Author(s): Rofila Dita Karmia , Mefri Yanni , Yusrawati , et al Added: 3 months ago

Inherited and Congenital Cardiac Conditions

Electrophysiology & Arrhythmia
Cardiomyopathies: Management of Cardiomyopathies with Dr Michelle Kittleson
Author(s): Michelle Kittleson Added: 8 months ago
Learn about the management of HFrEF and HFpEF from Dr Michelle Kittleson (Cedars-Sinai Heart Institute, Los Angeles, US).This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.In this lecture, Dr Kittleson provides an in-depth review of the management of HFrEF… View more

Heart Failure
PREVENT Equations Define 30-Year CVD Risk Percentiles
Added: 4 months ago Source:  Radcliffe Cardiology
Communicating long-term cardiovascular disease (CVD) risk to younger adults can be challenging, but new research offers a tool to frame risk relative to an individual's peers. Investigators have developed population-based, age- and sex-specific percentiles for 30-year risk of CVD, atherosclerotic cardiovascular disease (ASCVD), and heart failure (HF) using the PREVENT (Predicting Risk of CVD… View more

Prevention & Chronic Conditions

Demographic
ESC 24: Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC Congress 24 – Join Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful series of wrap-ups from the ESC Congress 2024 in London.Trials covered in detail include:FINEARTS-HFMRAs in Heart FailureSENIOR RITAEARTH-STEMISCOFFAVATARWatch the Day 1 and Day 2 ESC 24 wrap-ups from Dr Alasnag and Dr Al-Shaibi here.Recorded on-site at the ESC Congress… View more

Intervention

Heart Failure
ESC 2025 Hot Line & Late-Breaking Collection
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 8 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more

Imaging & Diagnostics

Intervention
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 1 year ago

CV Disease in Special Populations

Heart Failure
THT 2025: The SUMMIT Trial
Author(s): Barry Borlaug Added: 1 year ago
THT Conference 2025 - Outcomes assessing the effect of obesity severity on tirzepatide in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) show that patients on tirzepatide with a greater reduction in BMI and baseline waist-to-height ratio had greater improvements in exercise capacity and KCCQ quality of life scores.Dr Barry Borlaug (Mayo Clinic and Foundation,… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
ESC 25: Day 2 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 7 months ago
ESC Congress 2025 – The second day of ESC Congress 2025 brought forth significant findings with major implications for cardiovascular care.Interventional specialists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) share their expert analysis of the essential insights from the day's hot line trial presentations.Day 2 Highlights:MAPLE-HCMODYSSEY-HCMBETAMI… View more

Intervention

Heart Failure